Hideki Chuman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hideki Chuman has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Nobuhisa Nao-I
University of Miyazaki
2 shared publications- Akihiro Shinkai
Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan
1 shared publication - Akiko Kimura
Kind Eye Clinic, Kobe 650-0022, Japan
1 shared publication - Akiko Masuda
Department of Ophthalmology, Hyogo Medical University, Nishinomiya 663-8501, Japan
1 shared publication - Akiko Yamagami
Department of Ophthalmology, Inouye Eye Hospital, Tokyo 101-0062, Japan
1 shared publication - Hitoshi Mochizuki
Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
1 shared publication
Latest Publications
- Open Access
Efficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan
This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously received botulinum toxin treatment; 50 U for treatment-naïve patients), followed by flexible doses up to 100 U for 48 weeks, with at least 6-week intervals. In total, 29 Japanese patients were enrolled (26 [89.7%] women, mean age 64.6 years, mean baseline Jankovic Rating Scale [JRS] severity score 3.24). The primary endpoint, the least squares mean of change in JRS severity scores from baseline to 6 weeks after the first injection, was −2.08 (95% confidence interval: −2.49, −1.66), meeting the prespecified efficacy criteria. The secondary endpoint results (JRS severity, frequency, and total scores for 48 weeks; Blepharospasm Disability Index; Patient Evaluation of Global Response; and fast blinking test) supported the efficacy of repeated incobotulinumtoxinA injections. Adverse events (AEs) occurred in 19 (65.5%) patients, with eyelid ptosis being the most common treatment-related AE (4 [13.8%] patients). No severe or serious AEs were reported. IncobotulinumtoxinA demonstrated sustained efficacy in Japanese patients with blepharospasm, without new safety concerns. (Japan Registry of Clinical Trials identifier, jRCT2031230711)
Open AccessEfficacy and Safety of IncobotulinumtoxinA for the Treatment of Blepharospasm: A Multicenter, Phase 3 Study in Japan
This open-label, uncontrolled, single-arm, multicenter, phase 3 study evaluated the efficacy and safety of incobotulinumtoxinA in Japanese patients with blepharospasm. Eligible patients received incobotulinumtoxinA injections at fixed doses (50, 75, or 100 units [U] for those who had previously received botulinum toxin treatment; 50 U for treatment-naïve patients), followed by flexible doses up to 100 U for 48 weeks, with at least 6-week intervals. In total, 29 Japanese patients were enrolled (26 [89.7%] women, mean age 64.6 years, mean baseline Jankovic Rating Scale [JRS] severity score 3.24). The primary endpoint, the least squares mean of change in JRS severity scores from baseline to 6 weeks after the first injection, was −2.08 (95% confidence interval: −2.49, −1.66), meeting the prespecified efficacy criteria. The secondary endpoint results (JRS severity, frequency, and total scores for 48 weeks; Blepharospasm Disability Index; Patient Evaluation of Global Response; and fast blinking test) supported the efficacy of repeated incobotulinumtoxinA injections. Adverse events (AEs) occurred in 19 (65.5%) patients, with eyelid ptosis being the most common treatment-related AE (4 [13.8%] patients). No severe or serious AEs were reported. IncobotulinumtoxinA demonstrated sustained efficacy in Japanese patients with blepharospasm, without new safety concerns. (Japan Registry of Clinical Trials identifier, jRCT2031230711)
- Open Access
- 12 February 2019
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2019, 1-4
Optic Neuropathy with Features Suggestive of Optic Neuritis in Cerebrotendinous Xanthomatosis
We describe our encounter with a 39-year-old man who exhibited acute painless visual loss and progressive gait disturbance. He had tendinous xanthoma and several neuroophthalmological findings indicative of optic neuropathy in the right eye, including afferent pupillary defect, cecocentral scotoma, and optic disc swelling. Neurological examination showed cerebellar ataxia and pyramidal weakness. Brain magnetic resonance imaging revealed bilateral swelling in the optic nerves with gadolinium-enhancement suggesting optic neuritis, an enlarged fourth ventricle, atrophy of the cerebellum, and hyperintensities in the bilateral dentate nuclei. The patient was diagnosed with cerebrotendinous xanthomatosis (CTX) based on an elevated serum cholestanol level and a homozygous missense mutation in CYP27A1. CTX is a genetic lipid storage disease caused by dysfunction of the mitochondrial enzyme sterol 27-hydroxylase. With respect to ophthalmological manifestations, juvenile cataracts and optic neuropathy are common findings in patients with CTX, but there have been no reports of optic neuropathy with features suggestive of optic neuritis. Thus, this case illustrates that clinicians should consider a diagnosis of CTX in patients with cardinal features of CTX even if the patients show signs indicative of optic neuritis.
- 12 February 2019
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2019, 1-4
Open AccessOptic Neuropathy with Features Suggestive of Optic Neuritis in Cerebrotendinous Xanthomatosis
We describe our encounter with a 39-year-old man who exhibited acute painless visual loss and progressive gait disturbance. He had tendinous xanthoma and several neuroophthalmological findings indicative of optic neuropathy in the right eye, including afferent pupillary defect, cecocentral scotoma, and optic disc swelling. Neurological examination showed cerebellar ataxia and pyramidal weakness. Brain magnetic resonance imaging revealed bilateral swelling in the optic nerves with gadolinium-enhancement suggesting optic neuritis, an enlarged fourth ventricle, atrophy of the cerebellum, and hyperintensities in the bilateral dentate nuclei. The patient was diagnosed with cerebrotendinous xanthomatosis (CTX) based on an elevated serum cholestanol level and a homozygous missense mutation in CYP27A1. CTX is a genetic lipid storage disease caused by dysfunction of the mitochondrial enzyme sterol 27-hydroxylase. With respect to ophthalmological manifestations, juvenile cataracts and optic neuropathy are common findings in patients with CTX, but there have been no reports of optic neuropathy with features suggestive of optic neuritis. Thus, this case illustrates that clinicians should consider a diagnosis of CTX in patients with cardinal features of CTX even if the patients show signs indicative of optic neuritis.
- 23 October 2017
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 255 (12) , 2381-2388
Vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries in vitro and increased optic disc blood flow in vivo
This study aimed to clarify the vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries (PCAs) and to investigate changes in optic disc blood flow after an infusion of L-arginine in vivo.
- 23 October 2017
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 255 (12) , 2381-2388
Vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries in vitro and increased optic disc blood flow in vivo
This study aimed to clarify the vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries (PCAs) and to investigate changes in optic disc blood flow after an infusion of L-arginine in vivo.
- Open Access
- 27 September 2017
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 5 (2)
Adult T-Cell Leukemia/Lymphoma with Extraocular Muscle Infiltration a Case Report
- 27 September 2017
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 5 (2)
Open AccessAdult T-Cell Leukemia/Lymphoma with Extraocular Muscle Infiltration a Case Report
- Open Access
- 4 August 2017
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 4 (1)
Pediatric Cavernous Sinus Syndrome as the Initial Presentation of Intracranial Germinoma: A Case Report
- 4 August 2017
- Published by Juniper Publishers in JOJ Ophthalmology
- Vol. 4 (1)
Open AccessPediatric Cavernous Sinus Syndrome as the Initial Presentation of Intracranial Germinoma: A Case Report
- Open Access
- 1 January 2017
- Published by Allied Academies
- Vol. 01 (02)
Evaluation of optic disc blood flow of intraconal orbital tumors using laser speckle flowgraphy
An orbital tumor can alter the blood hemodynamics and cause a change to optic disc blood flow. We evaluated the bilateral optic disc blood flow of patients with unilateral orbital tumors using laser speckle flow graphy. The optic disc blood flow of the tumor side significantly decreased or increased compared with the optic disc of the fellow eye, even in patients with subtle or absent clinical symptoms and signs. Laser speckle flowgraphy of the optic disc showed the alteration of orbital hemodynamics with tumors and could be useful to suggest the existence of the orbital tumors.
- 1 January 2017
- Published by Allied Academies
- Vol. 01 (02)
Open AccessEvaluation of optic disc blood flow of intraconal orbital tumors using laser speckle flowgraphy
An orbital tumor can alter the blood hemodynamics and cause a change to optic disc blood flow. We evaluated the bilateral optic disc blood flow of patients with unilateral orbital tumors using laser speckle flow graphy. The optic disc blood flow of the tumor side significantly decreased or increased compared with the optic disc of the fellow eye, even in patients with subtle or absent clinical symptoms and signs. Laser speckle flowgraphy of the optic disc showed the alteration of orbital hemodynamics with tumors and could be useful to suggest the existence of the orbital tumors.